Low Molecular Weight Heparin Market – Opportunities in Key Application Sectors by 2025

The report "Low Molecular Weight Heparin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025 ", has been prepared based on an in-depth market analysis with inputs from industry experts.

The main objective of this report is to define, describe, and forecast the global “Low Molecular Weight Heparin” market on the basis of types of applications, major sectors, deployment models, organization size, and regions. The report contains an analysis of the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges). It aims to strategically analyze the micromarkets with respect to individual growth trends, prospects, and their contribution to the market. The report attempts to forecast the market size for 5 major regions, namely, North America, Europe, Asia Pacific (APAC), Middle East and Africa (MEA), and Latin America. It contains key vendor profiles and comprehensively analyzes their core competencies. The report also tracks and analyzes competitive developments, including partnerships, collaborations, acquisitions, new product developments, and R&D activities in the market.

Get Sample Copy of this report @ https://www.marketresearchreports.biz/sample/sample/1380617

Low molecular weight heparin is derived from an unfractionated heparin with an average molecular weight of less than 8,000 Da. Low molecular weight heparins are extracted by enzymatic or chemical depolymerization of unfractionated heparin. Low molecular weight heparins have fewer side effects as compared to unfractionated heparins, which involve lesser risk of heparin-induced osteopenia and heparin-induced thrombocytopenia (HIT). Currently, low molecular weight heparin forms the standard of care drugs and is widely used for the treatment and prophylaxis of arterial and venous thrombosis. Dose consideration for low molecular weight heparin depends on a patient’s weight. In 2014, researchers at the Rensselaer Polytechnic Institute and the University of North Carolina (UNC) developed a synthetic form of low molecular weight heparin that is safe and can be reversed in activity using an antidote called protamine. According to the research, this synthetic heparin is safer and cheaper than the available heparin which is derived from animals.

Proven benefits of low molecular weight heparin over unfractionated heparin are driving the demand for low molecular weight heparin globally, which in turn is fuelling the growth of the market. The demand for low molecular weight heparin is expected to grow exponentially in the next few years due to increasing usage in surgeries and in the treatment of coagulation disorders. However, lack of its ability to reverse the effect of overdose resulting in the development of HIT and other bleeding disorders restrains the growth of the global low molecular weight heparin market.

The global low molecular weight heparin market is segmented on the basis of type of molecule, type of packaging, dosing by body weight, approved indication, end-user, and region. In terms of type of molecule, the market is segmented into Lovenox (enoxaparin), Fragmin (Dalteparin), Innohep (tinzaparin), and others. Based on the type of packaging, the market is classified into multi-dose vial, single-dose vial, prefilled or preloaded syringe, unit dose syringe, and ampoule. On the basis of dosing by body weight, the market is categorized into 31 to 40 Kg, 41 to 50 Kg, 51 to 60 Kg, 61 to 70 Kg, 71 to 80 Kg, 81 to 90 Kg, and above 91 Kg.

View Full Report @ https://www.marketresearchreports.biz/reports/1380617/low-molecular-weight-heparin-market-research-reports

In terms of approved indication, the market is divided into prophylaxis in hip replacement surgery, prophylaxis in knee replacement surgery, prophylaxis in abdominal surgery, prophylaxis in acutely ill medical patients, secondary prophylaxis or extended treatment in cancer patients, inpatient treatment of deep vein thrombosis without pulmonary embolism, outpatient treatment of deep vein thrombosis with or without pulmonary embolism, unstable angina and non-ST elevated MI, and acute ST-elevation MI. In terms of end-user, the market is segmented into hospitals, nursing homes & private clinics, assisted living facilities & long-term care institutions, and home health care.

Geographically, the global low molecular weight heparin market is distributed over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe and North America hold a large market share owing to rise in the geriatric population that has an impact on the prevalence of venous thrombosis. The European Commission (Eurostat) stated that the geriatric population in Europe is estimated to reach 525 million by 2035. The Asia Pacific and Middle East & Africa markets are anticipated to grow during the forecast period due to increasing birth rate. The National Institute for Health and Care Excellence (NICE) and the Royal College of Obstetricians and Gynaecologists (RCOG) recommend low molecular weight heparin as the most appropriate heparin to be used during pregnancy due to its inability to cross the placenta.

Key players operating in the global low molecular weight heparin market include Sanofi S.A., Pfizer, Inc., LEO Pharma A/S, and Novartis AG.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Request For Enquiry @ https://www.marketresearchreports.biz/sample/enquiry/1380617

The study is a source of reliable data on:

Market segments and sub-segments
Market trends and dynamics
Supply and demand
Market size
Current trends/opportunities/challenges
Competitive landscape
Technological breakthroughs
Value chain and stakeholder analysis
The regional analysis covers:

North America (U.S. and Canada)
Latin America (Mexico, Brazil, Peru, Chile, and others)
Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
Eastern Europe (Poland and Russia)
Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

A complete backdrop analysis, which includes an assessment of the parent market
Important changes in market dynamics
Market segmentation up to the second or third level
Historical, current, and projected size of the market from the standpoint of both value and volume
Reporting and evaluation of recent industry developments
Market shares and strategies of key players
Emerging niche segments and regional markets
An objective assessment of the trajectory of the market
Recommendations to companies for strengthening their foothold in the market

About us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact us

Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz

This release was published on openPR.